The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.
about
Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010Renal function in Ghanaian HIV-infected patients on highly active antiretroviral therapy: a case-control studyRecurrent HIV-associated immune complex glomerulonephritis with lupus-like features after kidney transplantationRecent developments in HIV-related kidney disease.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy.Reduced renal function is associated with progression to AIDS but not with overall mortality in HIV-infected Kenyan adults not initially requiring combination antiretroviral therapy.African origins and chronic kidney disease susceptibility in the human immunodeficiency virus era.Renal disease in HIV-infected individualsAPOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease.Markers of renal disease and function are associated with systemic inflammation in HIV infection.Antiretroviral-treated HIV-infected women have similar long-term kidney function trajectories as HIV-uninfected women.Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients.Chronic kidney disease at presentation is not an independent risk factor for AIDS-defining events or death in HIV-infected persons.Update on cystatin C: incorporation into clinical practice.Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users.The molecular pathogenesis of HIV-1 associated nephropathy: recent advances.Renal issues in HIV infection.Impact of Age-related Comorbidities on Five-year Overall Mortality among Elderly HIV-Infected Patients in the Late HAART Era--Role of Chronic Renal Disease.Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients.Editorial commentary: Risks and benefits of tenofovir in the context of kidney dysfunction in sub-Saharan Africa.
P2860
Q27690715-06E6C135-5D1E-401F-9139-DD6BA7538083Q28539647-AF6DE727-EF39-47F8-9A2B-C83F3FD981E8Q34000738-8CF383C7-758D-47BE-B114-2D70BC79B56CQ34572458-DCDEB4F4-DA71-49FF-B6A5-3270E60F1550Q34736194-7C4E7CAF-05FB-492F-8921-EA76FFCAD022Q35059316-920EE0CC-777D-43B5-BEFD-2F83C288FCAFQ35074209-C0F9B197-54A4-4D26-B62C-75998597D332Q35567885-9F92E7CE-1EF1-47D0-9B33-BA02D59162DFQ35698442-864E86FB-9459-4AFE-976C-FE1386009F09Q35715828-4DDA4E6E-A81B-40EE-9D23-06BA990B4552Q36206108-281AEBFB-9275-40CC-9734-90238C6433F0Q36795839-94CABECA-5128-4F18-AAE1-92556FFCB4CEQ36852879-3FACAD6E-A01C-466B-A84D-61EFA3E72643Q37053111-1898DD1E-B837-4CEE-9F19-973BF8950D08Q37126287-2C9E4722-C590-4CE3-82B3-12C22427DE6EQ37155210-C283DF4B-C49E-4D3D-B929-B4BEAAF985A0Q37827370-BD5EBE61-5940-4857-80D8-3DB0EEBF1601Q37885232-9F3EFD31-63E2-489B-AC48-58B4193DFE67Q40747316-6D2C79CA-B1EB-4625-BECC-915F89170CAFQ41204065-A8FAF44D-C826-47D3-B6A2-80EA31796DC4Q42539731-0E031BD4-3F7B-4764-B0D9-941DC40ACF5B
P2860
The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The impact of kidney function ...... rtality in HIV-infected women.
@ast
The impact of kidney function ...... rtality in HIV-infected women.
@en
type
label
The impact of kidney function ...... rtality in HIV-infected women.
@ast
The impact of kidney function ...... rtality in HIV-infected women.
@en
prefLabel
The impact of kidney function ...... rtality in HIV-infected women.
@ast
The impact of kidney function ...... rtality in HIV-infected women.
@en
P2093
P2860
P1476
The impact of kidney function ...... rtality in HIV-infected women.
@en
P2093
Alison Abraham
Brad C Astor
C Leigh Pearce
Daniel J Merenstein
Jack A Dehovitz
Kathryn Anastos
Lynda A Szczech
Mardge H Cohen
Michelle M Estrella
Phyllis C Tien
P2860
P304
P356
10.1097/QAI.0B013E3181E674F4
P407
P577
2010-10-01T00:00:00Z